Clinical trials recruiting for Homologous Recombination Deficiency
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Arizona | 1 |
| Florida | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Missouri | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| South Carolina | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- Bipolar Androgen Therapy + Carboplatin in mCRPC
- Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
- Olaparib in Patients With HRD Malignant Mesothelioma
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Related conditions
Trials recruiting for Homologous Recombination Deficiency often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Homologous Recombination Deficiency trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.